Adoption of the Income Statement and the Balance Sheet

The Annual General Meeting adopted the Income Statement and the Balance Sheet as well as the Consolidated Income Statement and the Consolidated Balance Sheet for the financial year 2022.

Dividend

In accordance with the proposal of the Board of Directors and the CEO, the Annual General Meeting resolved to declare a dividend of SEK 0,85 per share. 24 April 2023 was determined as record date for dividend and the dividend is expected to be distributed by Euroclear Sweden AB starting 27 April 2023.

Discharge from liability

The Board members and the CEO were discharged from liability for their administration of the company for the financial year 2022.

Election of Board of Directors

Johan Malmquist (Chairman), Carl Bennet, Eva Elmstedt, Dan Frohm, Ulf Grunander, CarolaLemne and Joacim Lindoff were re-elected as members of the Board.

Fees to the Board of Directors

It was resolved that remuneration to the Board of Directors shall amount to a total of SEK4942125 excluding remuneration for Committee work, of which SEK1,578,375 to the Chairman and SEK672,750 to each of the other Board members elected by the Meeting who are not employees of Arjo Group. In addition hereto, the Meeting resolved that work in the Audit Committee shall be compensated with SEK279,450 to the Chairman and SEK139,725 to each of the other members, while work in the Remuneration Committee shall be compensated with SEK150,075 to the Chairman and SEK106,605 to each of the other members.

Election of auditors

The registered public accounting firm Öhrlings PricewaterhouseCoopers AB was re-elected auditor of the company for a term of one year. The public accounting firm has informed that Cecilia Andrén Dorselius will be the auditor in charge. It was resolved that auditor fees shall be paid in accordance with approved account.

Remuneration report

The Annual General Meeting resolved to approve the Board of Directors' report over remuneration in accordance with Chapter 8 section 53 a, the Swedish Companies Act, regarding the financial year 2022.

For more information, please contact:

Maria Nilsson, (Acting) EVP Marketing Communications & Public Relations
Tel: +46(0)10 335 4866
E-mail: maria.nilsson@arjo.com

Sara Ehinger, VP Investor Relations & Corporate Communications
Tel: +46 (0)10 335 4554
Email: sara.ehinger@arjo.com

About Arjo

At Arjo, we believe that empowering movement within healthcare environments is essential to quality care. Our products and solutions are designed to promote a safe and dignified experience through patient handling, medical beds, personal hygiene, disinfection, diagnostics, and the prevention of pressure injuries and venous thromboembolism. With 6,800 people worldwide and 65years caring for patients and healthcare professionals, we are committed to driving healthier outcomes for people facing mobility challenges.